Erythropoietin for patients undergoing radiotherapy: a pilot study.

[1]  D. Nicolae,et al.  Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial. , 1998, British Journal of Cancer.

[2]  C. Helmers,et al.  Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Roser,et al.  Hemoglobin levels predict local regional control after postoperative radiotherapy for advanced head and neck cancer , 1997 .

[4]  C. Brugnara,et al.  The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin , 1997, British journal of haematology.

[5]  B. Maciejewski,et al.  Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. , 1997, International journal of radiation oncology, biology, physics.

[6]  W. Hörl,et al.  Erythropoietin and iron. , 1997, Clinical nephrology.

[7]  F. Mercuriali,et al.  Comparison between Intravenous and Subcutaneous Recombinant Human Erythropoietin (Epoetin Alfa) Administration in Presurgical Autologous Blood Donation in Anemic Rheumatoid Arthritis Patients Undergoing Major Orthopedic Surgery , 1997, Vox sanguinis.

[8]  I. Macdougall,et al.  A randomized controlled study of iron supplementation in patients treated with erythropoietin. , 1996, Kidney international.

[9]  W. Hörl,et al.  Safety of intravenous injection of iron saccharate in haemodialysis patients. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  H. Allgayer,et al.  Perisurgical erythropoietin application in anemic patients with colorectal cancer: A double-blind randomized study. , 1996, Surgery.

[11]  W. Curran,et al.  Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Twiggs,et al.  Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. , 1994, International journal of radiation oncology, biology, physics.

[13]  C. Ewing,et al.  Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial. , 1993, International journal of radiation oncology, biology, physics.

[14]  R. Lavey,et al.  Erythropoietin increases hemoglobin in cancer patients during radiation therapy. , 1993, International journal of radiation oncology, biology, physics.

[15]  J. Spivak.  The application of recombinant erythropoietin in anemic patients with cancer. , 1992, Seminars in oncology.

[16]  D. Henry,et al.  Changing patterns of care in the management of anemia. , 1992, Seminars in oncology.

[17]  J. Adamson.  Management of anemia in oncology. Introduction. , 1992, Seminars in Oncology.

[18]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[19]  H. Thames,et al.  Clinical radiobiology of squamous cell carcinoma of the oropharynx. , 1991, International journal of radiation oncology, biology, physics.

[20]  F. Cartei.  P38 25 TP – IRRADIATION AND ERYTHROPOIETIN (rHuEPO) IN TREATMENT OF CANCER , 1991 .

[21]  S. Dische.  Radiotherapy and anaemia--the clinical experience. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  A. Little,et al.  Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. , 1990, American journal of surgery.

[23]  M. Hendrickson,et al.  The clinical significance of blood transfusion at the time of radical hysterectomy , 1990, Obstetrics and gynecology.

[24]  H. Gisslinger,et al.  Erythropoietin treatment of anemia associated with multiple myeloma. , 1990, The New England journal of medicine.

[25]  R. Mertelsmann,et al.  Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. Kerridge,et al.  Blood transfusion and survival following surgery for prostatic carcinoma , 1990, The British journal of surgery.

[27]  J. Overgaard,et al.  Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. , 1989, International journal of radiation oncology, biology, physics.

[28]  A. Gerbaulet,et al.  Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. , 1989, International journal of radiation oncology, biology, physics.

[29]  J. Overgaard.  Sensitization of hypoxic tumour cells--clinical experience. , 1989, International journal of radiation biology.

[30]  H. Perkins.  Transfusion-induced immunologic unresponsiveness. , 1988, Transfusion medicine reviews.

[31]  R. Walker,et al.  Special report: transfusion risks. , 1987, American journal of clinical pathology.

[32]  T. Pajak,et al.  Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck. , 1987, International journal of radiation oncology, biology, physics.

[33]  T. Poskitt.  Radiation therapy and the role of red blood cell transfusion. , 1987, Cancer investigation.

[34]  R. Bush.  The significance of anemia in clinical radiation therapy. , 1986, International journal of radiation oncology, biology, physics.

[35]  J. Overgaard,et al.  Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival. , 1986, International journal of radiation oncology, biology, physics.

[36]  M. Agarwal,et al.  Relation between recurrence of cancer of the colon and blood transfusion. , 1985, British medical journal.

[37]  H. Suit,et al.  Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancer , 1984 .

[38]  R. Drzymala,et al.  Interstitial brain irradiation by removable high-intensity iridium-192: Pre-clinical evaluation, dosimetric planning and bedside shielding , 1984 .

[39]  P. Schwartz,et al.  Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival. , 1983, International journal of radiation oncology, biology, physics.

[40]  A J Dembo,et al.  Definitive evidence for hypoxic cells influencing cure in cancer therapy. , 1978, The British journal of cancer. Supplement.

[41]  J. M. Thomson,et al.  Factors affecting survival in over 500 patients with stage II carcinoma of the cervix. , 1977, Radiology.

[42]  J. Sirácky,et al.  The effect of anemia on the radiotherapy results of the uterine cervix cancer. , 1975, Neoplasma.

[43]  F. George,et al.  Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer. , 1973, Radiology.

[44]  Taskinen Pj.  Radiotherapy and TNM classification of cancer of the larynx. A study based on 1447 cases seen at the Radiotherapy Clinic of Helsinki during 1936-1961. , 1968 .

[45]  P. Bergsjø,et al.  THE INFLUENCE OF ANEMIA ON THE RESULTS OF RADIOTHERAPY IN CARCINOMA OF THE CERVIX. , 1965, Radiology.